Find clinical trials for Endometrial Cancer in London, England
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near London, England, GBR:
Phase Ia study of Atezolizumab (NCT01375842) monotherapy in relapsed endometrial cancer were reported as abstract at ASCO 2017. Fif...
Phase 3
London, United Kingdom and 92 other locations
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...
Phase 2, Phase 3
London, United Kingdom and 13 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
London, London, City Of, United Kingdom and 218 other locations
participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....
Phase 3
London, United Kingdom and 162 other locations
choice (doxorubicin or paclitaxel) for the treatment of advanced endometrial cancer. Participants will be randomly assigned to rece...
Phase 3
London, United Kingdom and 168 other locations
durvalumab (MEDI4736) in patients with relapsed gynaecological cancers to assess the response in groups of patients selected based on their ...
Phase 2
London, United Kingdom and 8 other locations
This clinical trial is studying advanced or metastatic solid tumors. Once a solid tumor has grown very large in one spot or has spr ...
Phase 2
London, Other, United Kingdom and 48 other locations
) antibody (balstilimab), and to assess the maximum tolerated dose (MTD) in participants with advanced solid tumors. This study will also de...
Phase 1
London, United Kingdom and 18 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
London, London, City Of, United Kingdom and 230 other locations
The purpose of this trial is to measure the following in participants with solid tumors who receive GEN1047:* The side effects seen with GEN...
Phase 1, Phase 2
London, United Kingdom and 35 other locations
Clinical trials
Research sites
Resources
Legal